Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC

Clinical trial NCT04865250 · RECRUITING

Trial details

NCT number: NCT04865250
Sponsor: University Hospital Heidelberg
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Stage II NSCLC, Stage IIIA NSCLC Stage IIIB

Start date: 2021-01-07
Primary completion: 2024-11-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.